Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...

A recent study published in The American Journal of Gastroenterology examines the growing role complementary and alternative medicine is playing in the treatment of gastrointestinal conditions. The ...

Syma Iqbal, MD, discusses how ESCC and GI cancer treatment pathways may have a myriad of effects on patient quality of life. Syma Iqbal, MD, shares final insights into the ESCC and GI cancer treatment ...

Tiago Biachi, MD, PhD, highlighted the transformative role of personalized medicine in gastrointestinal (GI) cancer treatment through advances in next-generation sequencing and circulating tumor DNA, ...

A team of researchers at the University of Minnesota recently completed a human trial for a novel gene-editing treatment, which could provide hope to patients with late-stage gastrointestinal, or GI, ...

Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal ...

The Rome Foundation and LOGICNETS have partnered to develop an advanced online decision support system for the Rome Foundation’s multi-dimensional clinical profiles protocols. The Rome Foundation, a ...

Please provide your email address to receive an email when new articles are posted on . In my practice, understanding the distinction between functional and organic GI conditions, and the ...

Data presented at ASCO GI 2026 show spevatamig, an anti-CLDN18.2/CD47 bsAb, in combination with chemotherapy, has the potential to be an effective first-line (1L) treatment in patients with CLDN18.2 ...